Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-31, Stock:ABBV, The news for the past five days is as follows:
2018-05-23: NEWS1: After Hours Most Active for May 23, 2018 :  GE, F, BAC, MSFT, ABBV, CFG, INTC, CSCO, DCUD, MDLZ, AAPL, AMAT.NEWS2: After Hours Most Active for May 23, 2018 :  GE, F, BAC, MSFT, ABBV, CFG, INTC, CSCO, DCUD, MDLZ, AAPL, AMAT.NEWS3: Analysts Expect 10% Gains Ahead For The Holdings of FTHI.NEWS4: Analysts Expect 10% Gains Ahead For The Holdings of FTHI.NEWS5: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS6: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS7: Better Buy: AbbVie Inc. vs. Pfizer Inc..
2018-05-24: NEWS1: AbbVie Is The Amazon Of Biopharma — But Can It Keep Going?.NEWS2: IMBRUVICA® (ibrutinib) Plus GAZYVA® (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint.NEWS3: Is the Options Market Predicting a Spike in AbbVie (ABBV) Stock?.NEWS4: Wired News – CytomX Gets FDA Approval for Investigational New Drug Application, Triggers $25 Million Milestone Payment from AbbVie.NEWS5: AbbVie Says Phase 3 ILLUMINATE Trial Met Primary Endpoint Of Improvement In PFS.NEWS6: AbbVie Says Phase 3 ILLUMINATE Trial Met Primary Endpoint Of Improvement In PFS.
2018-05-25: NEWS1: After Hours Most Active for May 25, 2018 :  ABBV, KR, QQQ, IBM, V, CPE, LOW, SBUX, QCOM, TXN, CELG, INTC.NEWS2: After Hours Most Active for May 25, 2018 :  ABBV, KR, QQQ, IBM, V, CPE, LOW, SBUX, QCOM, TXN, CELG, INTC.NEWS3: AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint.NEWS4: AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint.NEWS5: AbbVie&apos;s Imbruvica&apos;s Phase III Study Meets Primary Endpoint.NEWS6: Analyzing Ionis’s Q1 Revenue Streams.
2018-05-29: NEWS1: After Hours Most Active for May 29, 2018 :  BAC, GE, CSCO, MSFT, JPM, QQQ, ABBV, WFC, SO, QCOM, FOXA, PEP.NEWS2: After Hours Most Active for May 29, 2018 :  BAC, GE, CSCO, MSFT, JPM, QQQ, ABBV, WFC, SO, QCOM, FOXA, PEP.NEWS3: What's in Store for Cooper Companies' (COO) Q2 Earnings?.NEWS4: What's in Store for Cooper Companies' (COO) Q2 Earnings?.NEWS5: What&apos;s in Store for Cooper Companies&apos; (COO) Q2 Earnings?.NEWS6: AbbVie to Present at the Goldman Sachs 39th Annual Global Healthcare Conference.
2018-05-30: NEWS1: AbbVie Announces Updated Preliminary Results of Tender Offer.NEWS2: Why AbbVie&apos;s Blockbuster Humira Is Already In Trouble This Year.NEWS3: Health Care Sector Update for 05/30/2018: EXAS,ABBV,CTRV,TXMD.NEWS4: Health Care Sector Update for 05/30/2018: EXAS,ABBV,CTRV,TXMD.NEWS5: Noteworthy Wednesday Option Activity: ABBV, GS, DG.NEWS6: Noteworthy Wednesday Option Activity: ABBV, GS, DG.NEWS7: Health Care Sector Update for 05/30/2018: ABBV,CTRV,TXMD.NEWS8: Health Care Sector Update for 05/30/2018: ABBV,CTRV,TXMD.NEWS9: AstraZeneca (AZN) Stock on Growth Path This Year: Here's Why.NEWS10: AstraZeneca (AZN) Stock on Growth Path This Year: Here's Why.NEWS11: Credit Suisse Downgrades AbbVie On Humira Competitive Concerns.NEWS12: Pre-Market Most Active for May 30, 2018 :  ABBV, DKS, TVIX, MU, BAC, TXMD, TLT, QQQ, AKS, DB, CHK, SQQQ.NEWS13: Pre-Market Most Active for May 30, 2018 :  ABBV, DKS, TVIX, MU, BAC, TXMD, TLT, QQQ, AKS, DB, CHK, SQQQ.NEWS14: AbbVie Announces Preliminary Results of Tender Offer.NEWS15: How Are Merck’s Virology and Immunology Segments Positioned?.NEWS16: Is AbbVie Inc. (ABBV) a Buy?.NEWS17: Is AbbVie Inc. (ABBV) a Buy?.NEWS18: Is AbbVie Inc. (ABBV) a Buy?.

Answer: Decrease